U.S. Telecom Services and Carriers Stock News

NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

Can Rigetti (RGTI) Turn Its New 108-Qubit System Into a Scalable Quantum Business Model?

Earlier this week, Rigetti Computing announced the general availability of its 108-qubit Cepheus-1-108Q quantum system, built on a modular chiplet-based architecture and offered via its Quantum Cloud Services platform and Amazon Braket. This launch underscores Rigetti’s ambition to deliver scalable, higher-performance quantum hardware even as the company continues to contend with weak revenue and widening losses. We’ll now examine how the rollout of Cepheus-1-108Q could influence Rigetti’s...
NYSE:MLM
NYSE:MLMBasic Materials

A Look At Martin Marietta Materials (MLM) Valuation As Earnings Expectations Are Trimmed

Earnings expectations put Martin Marietta Materials (MLM) in focus Martin Marietta Materials (MLM) heads into its upcoming quarterly report with expectations for year-over-year earnings growth, but analysts have recently trimmed EPS estimates and flagged a negative Earnings ESP, increasing attention on the potential results. See our latest analysis for Martin Marietta Materials. At a share price of $615.30, Martin Marietta Materials has a 30 day share price return of 4.39% but a 90 day share...
NYSE:CI
NYSE:CIHealthcare

Is Cigna Group (CI) Now An Opportunity After A 16% Share Price Slide?

Wondering if Cigna Group at around US$275.64 is a bargain or a value trap? This article walks through what that price could actually represent for you. The stock is down 16.1% over the last year, with a 1.1% decline in the last week and a 1.2% decline year to date, but it has a 2.0% return over the last 30 days that hints at shifting sentiment. Recent coverage has focused on how Cigna Group fits into the broader US healthcare insurance space, including its scale in medical benefits and its...
NYSE:ELAN
NYSE:ELANPharmaceuticals

A Look At Elanco (ELAN) Valuation As Strong Revenue Growth Meets Softer EPS Guidance

Earnings reaction and investor focus Elanco Animal Health (ELAN) recently reported year on year revenue growth of 12.2% that came in ahead of expectations, while guidance for next quarter EPS fell short, creating a mixed starting point for investor debate. See our latest analysis for Elanco Animal Health. At a share price of $22.75, Elanco has seen a 1 day share price return of 1.61% but a 30 day share price return decline of 10.78%, while the 1 year total shareholder return of about 140%...
NasdaqCM:EGBN
NasdaqCM:EGBNBanks

Eagle Bancorp (EGBN) Q1 EPS Of US$0.48 Tests Turnaround Narratives After TTM Losses

Q1 2026 earnings snapshot Eagle Bancorp (EGBN) opened Q1 2026 with total revenue of US$64.8 million and basic EPS of US$0.48, alongside net income of US$14.7 million. This gives investors fresh numbers to weigh against a trailing twelve month profile where revenue was US$21.4 million and EPS was a loss of US$4.03. Over recent quarters the company has reported revenue of US$64.3 million in Q4 2024, US$47.9 million in Q1 2025 and US$64.8 million in Q1 2026, while quarterly EPS shifted from...
NYSE:EW
NYSE:EWMedical Equipment

Edwards Lifesciences (EW) Q1 Net Margin Compression Tests Bullish Growth Narratives

Edwards Lifesciences (EW) opened 2026 with Q1 revenue of US$1,648.6 million and basic EPS of US$0.66, setting the tone for how its earnings story is evolving off a higher revenue base and solid per share profit. Over the past five quarters, revenue has moved from US$1,385.8 million in Q4 2024 to US$1,412.7 million in Q1 2025 and US$1,648.6 million in the latest quarter, while quarterly basic EPS has ranged from US$0.11 in Q4 2025 to US$0.66 in Q1 2026. This gives investors a clearer view of...
NasdaqGS:PCB
NasdaqGS:PCBBanks

PCB Bancorp (PCB) Q1 EPS Lift Challenges Cautious Profitability Narratives

PCB Bancorp (PCB) opened Q1 2026 with total revenue of US$29.7 million and basic EPS of US$0.75, alongside trailing twelve month revenue of US$116.1 million and EPS of US$2.80. This provides a clear snapshot of both the quarter and the recent earnings run rate. Over the past year, revenue has moved from US$96.3 million in Q4 2024 to US$116.1 million on a trailing basis, while EPS has gone from US$1.75 to US$2.80, placing this result against a period of higher net profit margins and a 42.5%...
NasdaqGS:ABNB
NasdaqGS:ABNBHospitality

Is It Time To Reconsider Airbnb (ABNB) After Its Recent Share Price Climb?

Wondering if Airbnb's share price lines up with its real worth, or if the current market view is off the mark. Airbnb shares last closed at US$142.82, with returns of 0.9% over 7 days, 8.4% over 30 days, 7.4% year to date, 16.6% over 1 year, 19.3% over 3 years and a 17.3% decline over 5 years. Recent moves in the stock have put fresh attention on how the market is pricing Airbnb's role in global travel and short term stays. Broader conversations about travel demand, regulation of short term...
NasdaqGS:FISI
NasdaqGS:FISIBanks

Financial Institutions (FISI) Q1 EPS Strength Reinforces Bullish Profitability Narratives

Financial Institutions (FISI) opened 2026 with Q1 revenue of US$60.4 million and basic EPS of US$1.05, alongside trailing twelve month revenue of US$239.4 million and EPS of US$3.88 that reflects its recent return to profitability. Over recent quarters, the company has seen revenue move from US$54.3 million in Q1 2025 to a range around US$60 million, while quarterly EPS shifted from US$0.82 in Q1 2025 to US$0.98 in Q4 2025 and then US$1.05 in Q1 2026. This sets up this release as a snapshot...
NYSE:BY
NYSE:BYBanks

Byline Bancorp (BY) Q1 2026 Net Margin Strengthens Consensus Earnings Slowdown Narrative

Byline Bancorp (BY) has put up a solid Q1 2026 print, with revenue at US$106.9 million and basic EPS of US$0.84, supported by trailing 12 month revenue of US$422.9 million and EPS of US$3.09 that keep the earnings trend in focus. Over recent quarters, revenue has moved from US$93.9 million in Q1 2025 to US$106.9 million in Q1 2026, while basic EPS has shifted from US$0.65 to US$0.84, giving you a clear picture of how the top and bottom line are tracking into the new year. With a trailing net...
NYSE:HTB
NYSE:HTBBanks

HomeTrust Bancshares (HTB) Q1 Earnings Beat Narrative With 31.4% Net Margin Profile

HomeTrust Bancshares (HTB) opened Q1 2026 with total revenue of US$54.0 million and basic EPS of US$1.01, alongside trailing 12 month revenue of US$210.6 million and basic EPS of US$3.92 that reflect the earnings profile coming into this quarter. Over recent periods, the company has seen revenue move from US$49.4 million and EPS of US$0.84 in Q1 2025 to US$53.1 million and EPS of US$1.00 in Q2 2025, then to US$51.4 million and EPS of US$0.94 in Q4 2025. This sets up Q1 2026 as another quarter...
NYSE:CUBI
NYSE:CUBIBanks

Customers Bancorp (CUBI) Q1 Earnings Margin Of 29% Tests Bullish Narratives

Customers Bancorp (CUBI) opened 2026 with Q1 revenue of US$202.3 million and basic EPS of US$2.04, setting a clear marker against a trailing twelve month revenue base of US$808.0 million and EPS of US$8.16. Over recent quarters the company has seen revenue move from US$146.2 million in Q4 2024 to US$214.6 million in Q4 2025 before landing at US$202.3 million in Q1 2026. Quarterly basic EPS shifted from US$0.74 to US$2.05 and now US$2.04, giving investors a fuller read on earnings power...
NYSE:RS
NYSE:RSMetals and Mining

Reliance Steel Q1 EPS Jump Tests Bulls On Data Center And Infrastructure Resilience

Reliance (RS) has opened Q1 2026 with revenue of US$4.0b and basic EPS of US$5.13, setting the tone for how investors will judge the latest set of numbers against recent history. Over the last six quarters, revenue has moved from US$3.1b in Q4 2024 to US$3.5b in Q1 2025 and now US$4.0b, while basic EPS has shifted from US$1.95 to US$3.76 and now US$5.13, giving you a clear view of how the top and bottom lines are currently pairing up. With a trailing net margin of 5.4% that sits just below...
NYSE:KNSL
NYSE:KNSLInsurance

Kinsale Capital Group (KNSL) Net Margin Strength Tests Bearish Earnings Narratives

Kinsale Capital Group (KNSL) opened 2026 with Q1 revenue of US$466.7 million and basic EPS of US$4.90, setting the tone for how its specialty insurance book is currently feeding through to the bottom line. Over the past year, the company has seen trailing twelve month revenue move from US$1.64 billion to US$1.92 billion, while basic EPS over the same trailing period shifted from US$17.49 to US$22.82. This gives investors a clear view of how top line and per share earnings have tracked...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Synopsys Extends TSMC And Atomera Ties As Valuation Stays Near Target

Synopsys (NasdaqGS:SNPS) is expanding its work with TSMC to support advanced AI and 3D packaging design using its EDA, IP, and 3DIC tools. The company is also deepening its partnership with Atomera to model advanced gallium nitride, or GaN, devices for RF and power applications. For investors tracking semiconductor design tools, Synopsys sits at the center of chip development flows, with shares recently trading at $500.82. The stock has returned 22.1% over the past 30 days and 34.9% over 3...
NYSE:GPC
NYSE:GPCRetail Distributors

Is Genuine Parts (GPC) Pricing Misaligned With Cash Flow Value After Recent Share Pullback

If you are wondering whether Genuine Parts at around US$108.74 offers real value or just looks cheap on the surface, this article walks through the key signals to help you decide where it might sit on your watchlist. The stock has been choppy, with a 4.4% decline over the past week, a 3.4% gain over the last month, and returns of 12.3% decline year to date and 3.7% decline over the past year, which can change how the market is framing both risk and opportunity. Recent coverage has focused on...
NYSE:ITW
NYSE:ITWMachinery

How Investors Are Reacting To Illinois Tool Works (ITW) Extending Its 50-Year Dividend Growth Streak

Illinois Tool Works recently raised its 2026 dividend by 7%, extending a streak of more than 50 years of consecutive annual increases and reinforcing its reputation as a resilient industrial dividend payer. This decision highlights how ITW’s proprietary 80/20 Front-to-Back Process, which concentrates on its highest-margin customers and products, supports consistent cash generation even amid global uncertainty. Next, we'll explore how ITW's latest dividend increase refines the existing...
NYSE:MC
NYSE:MCCapital Markets

A Look At Moelis (MC) Valuation After Recent Share Price Strength And Long Term Returns

Moelis stock snapshot after recent performance moves Moelis (MC) has attracted attention after a recent share price move, with the stock closing at US$68.08. Investors are weighing that level against its recent performance across the past month, past 3 months and longer horizons. See our latest analysis for Moelis. The recent 23.11% 1-month share price return contrasts with a weaker 90-day share price return of a 7.55% decline. At the same time, the 1-year total shareholder return of 35.10%...
NYSE:COP
NYSE:COPOil and Gas

A Look At ConocoPhillips (COP) Valuation As Renewed Interest Follows Favorable Fundamentals And 2026 Spending Plans

Why recent coverage is focusing on ConocoPhillips Recent coverage has highlighted ConocoPhillips (COP) for its higher return on equity, lower debt load, stronger dividend yield, and a sizeable US$12b capital spending plan for 2026, drawing fresh attention from income and growth focused investors. See our latest analysis for ConocoPhillips. ConocoPhillips’ share price has climbed 23.8% over the past 90 days and 25.9% year to date, while its 1 year total shareholder return of 37.3% reflects...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

Ocular Therapeutix (OCUL) Is Up 8.2% After Positive Phase 3 AXPAXLI Data and FDA Feedback - What's Changed

Earlier in April 2026, Ocular Therapeutix reported additional positive Week 52 data from its Phase 3 SOL-1 trial, showing AXPAXLI (OTX-TKI) delivered superior durability, sustained disease control, and a generally well-tolerated safety profile versus aflibercept in treatment‑naïve wet AMD patients. The update also highlighted that recent FDA commentary supports the company’s plan to seek approval for AXPAXLI based on this single, well-controlled Phase 3 trial, potentially shortening the path...
NYSE:CRK
NYSE:CRKOil and Gas

How Investors Are Reacting To Comstock Resources (CRK) Backing NextEra’s Texas Gas Power Hub Plan

In March 2026, NextEra Energy announced that Comstock Resources’ Western Haynesville operations will support the newly designated Texas Natural Gas-Fired Power Generation Hub in Anderson County, Texas, which aims to deliver up to 5.2 GW of gas-fired capacity. This collaboration could open a substantial new outlet for Comstock’s Haynesville gas, potentially aligning long-term production with growing Texas power demand. Next, we’ll examine how this power generation hub collaboration could...
NYSE:DOCS
NYSE:DOCSHealthcare Services

Is It Time To Reassess Doximity (DOCS) After Its Steep Share Price Slide

If you are wondering whether Doximity's current share price reflects its true worth, you are not alone. This article breaks down what the latest data says about value. The stock recently closed at US$23.17, with returns of a 4.5% decline over 7 days, a 4.8% decline over 30 days, a 46.5% decline year to date and a 58.8% decline over the past year. These moves have put more attention on how the market is currently pricing Doximity and whether sentiment has shifted too far in one direction...
NasdaqGS:TSCO
NasdaqGS:TSCOSpecialty Retail

Reassessing Tractor Supply (TSCO) After Recent Share Price Slide And Valuation Signals

If you are wondering whether Tractor Supply's current share price lines up with its underlying value, or if the recent pullback has opened a window, this article walks through the key signals to help you frame that question. The stock closed at US$38.17, with returns of a 14.5% decline over 7 days, a 16.1% decline over 30 days and a 24.9% decline year to date, alongside a 20.8% decline over 1 year, a 15.9% decline over 3 years and an 8.9% gain over 5 years. Recent coverage has focused on...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

A Look At Workday (WDAY) Valuation After New AI Financial Suite And Fresh Client Wins

Workday (WDAY) is back in focus after rolling out its AI powered Financial Test Suite for fraud and anomaly detection, alongside fresh client wins such as EZE Cloud Consulting’s full scale HCM and Financial Management deployment. See our latest analysis for Workday. Despite recent AI product launches and new client deployments, Workday’s 30 day share price return of an 11.31% decline, 90 day share price return of a 39.41% decline, and 1 year total shareholder return of a 51.59% decline point...